View in EDS

Targeting BET proteins improves the therapeutic efficacy of BCL-2 inhibition in T-cell acute lymphoblastic leukemia.

Saved in:
Bibliographic Details
Title: Targeting BET proteins improves the therapeutic efficacy of BCL-2 inhibition in T-cell acute lymphoblastic leukemia.
Authors: Peirs S; Center for Medical Genetics, Ghent University, Ghent, Belgium.; Cancer Research Institute Ghent (CRIG), Ghent, Belgium., Frismantas V; Department of Pediatric Oncology, Children's Research Centre, University Children's Hospital Zurich, Zurich, Switzerland., Matthijssens F; Center for Medical Genetics, Ghent University, Ghent, Belgium.; Cancer Research Institute Ghent (CRIG), Ghent, Belgium., Van Loocke W; Center for Medical Genetics, Ghent University, Ghent, Belgium.; Cancer Research Institute Ghent (CRIG), Ghent, Belgium., Pieters T; Center for Medical Genetics, Ghent University, Ghent, Belgium.; Cancer Research Institute Ghent (CRIG), Ghent, Belgium.; Molecular and Cellular Oncology Lab, VIB Inflammation Research Center, Ghent University, Ghent, Belgium.; Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium., Vandamme N; Cancer Research Institute Ghent (CRIG), Ghent, Belgium.; Molecular and Cellular Oncology Lab, VIB Inflammation Research Center, Ghent University, Ghent, Belgium.; Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium., Lintermans B; Center for Medical Genetics, Ghent University, Ghent, Belgium.; Cancer Research Institute Ghent (CRIG), Ghent, Belgium., Dobay MP; Swiss Institute of Bioinformatics (SIB), Lausanne, Switzerland., Berx G; Cancer Research Institute Ghent (CRIG), Ghent, Belgium.; Molecular and Cellular Oncology Lab, VIB Inflammation Research Center, Ghent University, Ghent, Belgium.; Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium., Poppe B; Center for Medical Genetics, Ghent University, Ghent, Belgium.; Cancer Research Institute Ghent (CRIG), Ghent, Belgium., Goossens S; Center for Medical Genetics, Ghent University, Ghent, Belgium.; Cancer Research Institute Ghent (CRIG), Ghent, Belgium.; Molecular and Cellular Oncology Lab, VIB Inflammation Research Center, Ghent University, Ghent, Belgium.; Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium., Bornhauser BC; Department of Pediatric Oncology, Children's Research Centre, University Children's Hospital Zurich, Zurich, Switzerland., Bourquin JP; Department of Pediatric Oncology, Children's Research Centre, University Children's Hospital Zurich, Zurich, Switzerland., Van Vlierberghe P; Center for Medical Genetics, Ghent University, Ghent, Belgium.; Cancer Research Institute Ghent (CRIG), Ghent, Belgium.
Source: Leukemia [Leukemia] 2017 Oct; Vol. 31 (10), pp. 2037-2047. Date of Electronic Publication: 2017 Jan 11.
Publication Type: Comparative Study; Journal Article
Journal Info: Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 28074072
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Targeting BET proteins improves the therapeutic efficacy of BCL-2 inhibition in T-cell acute lymphoblastic leukemia.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Peirs+S%22">Peirs S</searchLink>; Center for Medical Genetics, Ghent University, Ghent, Belgium.; Cancer Research Institute Ghent (CRIG), Ghent, Belgium.<br /><searchLink fieldCode="AU" term="%22Frismantas+V%22">Frismantas V</searchLink>; Department of Pediatric Oncology, Children's Research Centre, University Children's Hospital Zurich, Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Matthijssens+F%22">Matthijssens F</searchLink>; Center for Medical Genetics, Ghent University, Ghent, Belgium.; Cancer Research Institute Ghent (CRIG), Ghent, Belgium.<br /><searchLink fieldCode="AU" term="%22Van+Loocke+W%22">Van Loocke W</searchLink>; Center for Medical Genetics, Ghent University, Ghent, Belgium.; Cancer Research Institute Ghent (CRIG), Ghent, Belgium.<br /><searchLink fieldCode="AU" term="%22Pieters+T%22">Pieters T</searchLink>; Center for Medical Genetics, Ghent University, Ghent, Belgium.; Cancer Research Institute Ghent (CRIG), Ghent, Belgium.; Molecular and Cellular Oncology Lab, VIB Inflammation Research Center, Ghent University, Ghent, Belgium.; Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium.<br /><searchLink fieldCode="AU" term="%22Vandamme+N%22">Vandamme N</searchLink>; Cancer Research Institute Ghent (CRIG), Ghent, Belgium.; Molecular and Cellular Oncology Lab, VIB Inflammation Research Center, Ghent University, Ghent, Belgium.; Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium.<br /><searchLink fieldCode="AU" term="%22Lintermans+B%22">Lintermans B</searchLink>; Center for Medical Genetics, Ghent University, Ghent, Belgium.; Cancer Research Institute Ghent (CRIG), Ghent, Belgium.<br /><searchLink fieldCode="AU" term="%22Dobay+MP%22">Dobay MP</searchLink>; Swiss Institute of Bioinformatics (SIB), Lausanne, Switzerland.<br /><searchLink fieldCode="AU" term="%22Berx+G%22">Berx G</searchLink>; Cancer Research Institute Ghent (CRIG), Ghent, Belgium.; Molecular and Cellular Oncology Lab, VIB Inflammation Research Center, Ghent University, Ghent, Belgium.; Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium.<br /><searchLink fieldCode="AU" term="%22Poppe+B%22">Poppe B</searchLink>; Center for Medical Genetics, Ghent University, Ghent, Belgium.; Cancer Research Institute Ghent (CRIG), Ghent, Belgium.<br /><searchLink fieldCode="AU" term="%22Goossens+S%22">Goossens S</searchLink>; Center for Medical Genetics, Ghent University, Ghent, Belgium.; Cancer Research Institute Ghent (CRIG), Ghent, Belgium.; Molecular and Cellular Oncology Lab, VIB Inflammation Research Center, Ghent University, Ghent, Belgium.; Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium.<br /><searchLink fieldCode="AU" term="%22Bornhauser+BC%22">Bornhauser BC</searchLink>; Department of Pediatric Oncology, Children's Research Centre, University Children's Hospital Zurich, Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Bourquin+JP%22">Bourquin JP</searchLink>; Department of Pediatric Oncology, Children's Research Centre, University Children's Hospital Zurich, Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Van+Vlierberghe+P%22">Van Vlierberghe P</searchLink>; Center for Medical Genetics, Ghent University, Ghent, Belgium.; Cancer Research Institute Ghent (CRIG), Ghent, Belgium.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228704895%22">Leukemia</searchLink> [Leukemia] 2017 Oct; Vol. 31 (10), pp. 2037-2047. <i>Date of Electronic Publication: </i>2017 Jan 11.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Comparative Study; Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group%2C+Specialist+Journals%22">Nature Publishing Group, Specialist Journals </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>8704895 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1476-5551 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2208876924%22">08876924 </searchLink><i>NLM ISO Abbreviation: </i>Leukemia <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=28074072
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/leu.2017.10
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2037
    Titles:
      – TitleFull: Targeting BET proteins improves the therapeutic efficacy of BCL-2 inhibition in T-cell acute lymphoblastic leukemia.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Peirs S
      – PersonEntity:
          Name:
            NameFull: Frismantas V
      – PersonEntity:
          Name:
            NameFull: Matthijssens F
      – PersonEntity:
          Name:
            NameFull: Van Loocke W
      – PersonEntity:
          Name:
            NameFull: Pieters T
      – PersonEntity:
          Name:
            NameFull: Vandamme N
      – PersonEntity:
          Name:
            NameFull: Lintermans B
      – PersonEntity:
          Name:
            NameFull: Dobay MP
      – PersonEntity:
          Name:
            NameFull: Berx G
      – PersonEntity:
          Name:
            NameFull: Poppe B
      – PersonEntity:
          Name:
            NameFull: Goossens S
      – PersonEntity:
          Name:
            NameFull: Bornhauser BC
      – PersonEntity:
          Name:
            NameFull: Bourquin JP
      – PersonEntity:
          Name:
            NameFull: Van Vlierberghe P
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 10
              Text: 2017 Oct
              Type: published
              Y: 2017
          Identifiers:
            – Type: issn-electronic
              Value: 1476-5551
          Numbering:
            – Type: volume
              Value: 31
            – Type: issue
              Value: 10
          Titles:
            – TitleFull: Leukemia
              Type: main
ResultId 1